AbbVie Outperforms S&P 500 This Year, With Three Major Long-Term Positive Factors Supporting Future Performance Jul 22, 2026 Life Science
Samsung Electronics Launches AI Health Assistant, Leveraging Ecosystem Advantages to Enter Competitive Red Ocean Jul 21, 2026 Life Science, Technology
Novo Nordisk Sues Eli Lilly Over ‘Deceptive’ GLP-1 Ads, Stock Impact Seen Limited Jul 21, 2026 Life Science
Cathie Wood’s Ark Invest Bets on Beam Therapeutics, with Multiple Clinical Catalysts Expected to Densely Materialize Over the Next 18 Months Jul 20, 2026 Life Science
A 54-Year Dividend Streak Meets a $10.9 Billion Acquisition: Here’s Why AbbVie’s Payouts Are Safe Jul 19, 2026 Life Science
Anti-Cancer Upstart’s Stock Surges 125% This Year as Billionaire Druckenmiller Builds Large Position Jul 18, 2026 Life Science
Oral Wegovy Dominates. Is Eli Lilly’s Trillion-Dollar Valuation Still Safe? Jul 17, 2026 Life Science
Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation Jul 17, 2026 Life Science
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs Jul 16, 2026 Life Science
Johnson & Johnson Posts Solid Quarter, Yet Wall Street Sells Off – What Spooked Investors? Jul 16, 2026 Life Science
Intuitive Surgical’s Stock Has Fallen Over 25% This Year, but Goldman Sachs Still Recommends Investors Buy Jul 15, 2026 Life Science
Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights Jul 14, 2026 Life Science
The Market Has Responded Coolly to Vertex’s Multibillion-Dollar Acquisition, but Management’s Track Record and Integration Capabilities Add Confidence to the Deal Jul 14, 2026 Life Science
The Panic of a Plunge Cannot Avoid Market Cycles, but Long-Term Holding of Quality Assets Can Secure the Final Victory Jul 11, 2026 Life Science, Technology
Core Business Steady Growth Coupled with Acquisition Tailwinds, Vertex Pharmaceuticals Demonstrates Strong Post-Market Momentum Jul 11, 2026 Life Science
Pfizer Could Rewrite the GLP-1 Race — but Its 7% Yield Is Flashing a Warning Jul 10, 2026 Life Science
